HUTCHMED (China) Limited

HMDCF ·Healthcare, Drug Manufacturers - General
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $71.3M $154.0M $283.6M $313.3M $377.5M $235.6M $121.2M $86.0M
Accounts Receivable $126.8M $155.5M $116.9M $98.0M $83.6M $47.9M $41.4M $40.2M
Inventory $41.1M $50.4M $50.3M $56.7M $35.8M $19.8M $16.2M $12.3M
Total Current Assets $1.57B $1.07B $1.10B $839.9M $1.21B $530.7M $317.0M $370.5M
Property, Plant & Equipment $94.6M $92.5M $99.7M $75.9M $41.3M $24.2M $20.9M $16.6M
Goodwill $3.1M $3.0M $3.1M $3.1M $3.4M $3.3M $3.1M $3.2M
Intangible Assets (Excl. Goodwill) $8.9M — $21.0K $85.0K $163.0K $227.0K $275.0K $347.0K
Total Assets $1.75B $1.27B $1.28B $1.03B $1.37B $724.1M $465.1M $532.1M
Liabilities
Accounts Payable $45.5M $42.5M $36.3M $71.1M $41.2M $31.6M $24.0M $25.6M
Total Current Liabilities $315.8M $376.6M $403.0M $353.9M $311.7M $158.4M $113.1M $85.5M
Long-Term Debt $68.2M $59.4M $48.2M $18.1M — $26.9M $26.8M $26.7M
Total Liabilities $501.8M $502.3M $536.4M $392.6M $333.1M $205.2M $152.2M $119.9M
Stockholders' Equity
Retained Earnings $-378.6M $-833.2M $-870.9M $-971.5M $-610.3M $-415.6M $-289.7M $-183.0M
Total Stockholders' Equity $1.24B $759.9M $730.5M $610.4M $986.9M $484.1M $288.0M $389.0M
← Newer Page 1 of 2 Older →